What a breast cancer second opinion can and cannot settle
The most useful second opinion answers a narrow question you can state in one sentence. Examples: is breast-conserving surgery reasonable given my tumour size and breast volume; does my pathology report support the hormone or HER2 treatment I have been offered; should I have chemotherapy before surgery; is reconstruction appropriate and when. A reviewer can comment on whether the records you send support the plan, and can raise alternatives. What a records-based review cannot do is examine you, feel the tumour, assess your breast in person or confirm that a particular operation is technically possible. Those judgements need a clinical examination and, often, local imaging.
This distinction matters for overseas patients. A Chinese specialist reading your file is giving a clinical opinion on the evidence in front of them. Our team's initial review is different: it is a free, non-clinical check of whether your diagnosis, records and main question are clear enough to route to the right specialty, and it identifies what is missing. Neither step replaces your treating team's assessment, and neither establishes that a hospital will accept you for treatment.
The records that make a breast cancer review meaningful
Breast cancer decisions rest on a small set of documents. The pathology report is central: tumour type, grade, size, lymph node status, oestrogen and progesterone receptor status, HER2 status and, where done, Ki-67 and any genomic assay. If your receptor results came from a core biopsy and the surgical specimen was later tested, send both, because results can differ and the reviewer needs to know which report the plan is based on. Imaging reports and the actual images matter too: mammography, breast ultrasound and any MRI, ideally on a disc or through a link the hospital can open rather than photographs of a screen.
Staging information should travel with the pathology: imaging of the chest, abdomen and bones if performed, and any PET or bone scan reports. Your current treatment plan, in writing, is what the second opinion is really testing, so include the proposed operation, the drugs and doses discussed, and any radiotherapy plan. A short chronological summary you write yourself, one page, saves the reviewer time and reduces the chance that a key event is missed. Ask the receiving clinician which formats and languages they can read; translation of pathology reports is a practical question to confirm with the specific hospital rather than assume.
Pathology re-review: why the tissue itself matters
In breast cancer, treatment hinges on receptor status and tumour grade, so an independent pathology review is often the most valuable part of a second opinion. A reviewing pathologist looks at your existing slides or tissue blocks, not just the written report, and comments on whether the diagnosis and markers are reproducible. This is a recognised part of cancer care in many health systems, and China has hospital pathology departments that perform it. Whether a particular hospital will re-read your slides, what material it needs and how long that takes are questions for that hospital.
The practical obstacle is physical: slides and paraffin blocks must be released by your original hospital and shipped under the right conditions. Ask your current pathology department what it can release, in what form, and whether it will send material directly to a named institution. If blocks cannot leave, ask whether the receiving pathologist will accept scanned slide images; some will comment on those, with limits. Do not assume that a written report alone can be re-reviewed to the same depth as the tissue itself.
Surgery, reconstruction and systemic therapy: separate decisions
Patients often arrive with one bundled question, but breast cancer care contains several decisions that can be reviewed separately. The surgical question is about the breast and the axilla: whether breast-conserving surgery or mastectomy is appropriate, whether sentinel node biopsy is planned, and what the expected cosmetic result is. Reconstruction is a distinct decision with its own risks, timing and suitability questions, and it should be discussed explicitly rather than assumed to be part of the cancer operation. If you are considering reconstruction in China, ask whether the team offers it as a separate, confirmed service and who would perform it.
The systemic question covers chemotherapy, endocrine treatment, HER2-directed therapy and other drugs, and it depends on stage, receptor status, menopausal status and your general health. Radiotherapy is a third decision, shaped by what surgery you have and what the pathology shows. A reviewer can comment on whether the plan matches your documented stage and markers, and can raise alternatives. They cannot promise that a given drug or regimen will be available to you in China, that a clinical trial place exists, or that a particular outcome will follow. Availability and eligibility are confirmed by the treating hospital, not by a coordinator or an article.
How to judge the opinion you receive
A good second opinion is specific and shows its reasoning. It should state which documents were reviewed, what the reviewer concluded, where the evidence is uncertain, and what additional information would change the recommendation. It should answer your actual question rather than offer a generic summary of breast cancer treatment. If the opinion recommends a different operation or drug plan, ask what evidence in your records supports the change and what would be needed to confirm it in person.
Be cautious with any opinion that promises a better outcome, a cure or a fixed survival figure. Breast cancer outcomes depend on many factors, and no reviewer can guarantee an individual result. Equally, be wary of an opinion produced without your pathology and imaging. Ask who reviewed the file, what their specialty is, and whether the review was a single clinician or a multidisciplinary discussion. Our team can arrange a review involving two or three relevant specialties for a complex case, with the scope and fee agreed first, but the clinical judgement remains with those specialists.
Practical next steps before you consider travelling
Start with your main question and a brief summary: diagnosis, date, stage if known, receptor status, treatment received so far and what you are deciding. Do not send passport numbers, card details or your complete archive at first contact. Our free initial case review checks whether the records and question are clear enough to route, and suggests the relevant next step. If a records-based specialist opinion would help, a proxy consultation is one optional route: our doctor takes your records to a relevant hospital specialist while you remain at home. It is not a prerequisite for every appointment or operation, and hospital consultation fees are separate.
If you later decide to travel, the hospital decides suitability and acceptance after seeing your records and, where needed, examining you. Ask the specific hospital what its written plan and quote include, which ward options exist, and what language support is available. Keep your current treatment team informed throughout; a second opinion is meant to inform your decision, not to interrupt care. For the clinical background, see our breast surgery reference and the oncology specialty page, and send a short summary when you are ready.
Sources & scope of this guide
References and official service information relevant to this guide.
- Breast surgery reference
- National Institute for Health and Care Excellence (NICE)
- National Cancer Institute
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
